Re-Aim Therapeutics

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Hillstar Bio

This biotechnology company develops precision immunology therapies that target and deplete pathogenic immune cells for patients with autoimmune diseases.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.

Dren

This company develops therapeutic antibodies to treat patients with cancer and autoimmune diseases by selectively depleting disease-causing cells.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

CheckmAb

This biotechnology company develops monoclonal antibody therapies for cancer and autoimmune disease patients by targeting regulatory T cells within pathological tissues.